Abstract:The beneficial and negative metabolites produced by gut microbiota. The gut microbiota produces all kinds of beneficial or negative metabolites and directly affects the intestinal barrier and gut hormone (GLP‐1 and PYY) release. After entering circulation, those metabolites regulate satiety, insulin release, adipose tissue function, and systemic immunity, thus influencing obesity and energy metabolism. Obesity is often associated with the risk of chronic inflammation and other metabolic diseases, such as diabetes, cardiovascular disease, and cancer. The composition and activity of the gut microbiota play an important role in this process, affecting a range of physiological processes, such as nutrient absorption and energy metabolism. The active gut microbiota can produce a large number of physiologically active substances during the process of intestinal metabolism and reproduction, including short‐chain/long‐chain fatty acids, secondary bile acids, and tryptophan metabolites with beneficial effects on metabolism, as well as negative metabolites, including trimethylamine N‐oxide, delta‐valerobetaine, and imidazole propionate. How gut microbiota specifically affect and participate in metabolic and immune activities, especially the metabolites directly produced by gut microbiota, has attracted extensive attention. So far, some animal and human studies have shown that gut microbiota metabolites are correlated with host obesity, energy metabolism, and inflammation. Some pathways and mechanisms are slowly being discovered. Here, we will focus on the important metabolites of gut microbiota (beneficial and negative), and review their roles and mechanisms in obesity and related metabolic diseases, hoping to provide a new perspective for the treatment and remission of obesity and other metabolic diseases from the perspective of metabolites.

Gut microbial metabolite short-chain fatty acids and obesity

Dietary Fiber and Its Potential Role in Obesity: A Focus on Modulating the Gut Microbiota

Dietary Gut Microbial Metabolites, Short-chain Fatty Acids, and Host Metabolic Regulation

From gut microbiota dysfunction to obesity: could short-chain fatty acids stop this dangerous course?

Gut and obesity/metabolic disease: Focus on microbiota metabolites

The Therapeutic Effect of SCFA-Mediated Regulation of the Intestinal Environment on Obesity

The Gut Microbial Regulation of Epigenetic Modification from a Metabolic Perspective

Gut Microbiota: a Potential Manipulator for Host Adipose Tissue and Energy Metabolism.

Commensal Homeostasis of Gut Microbiota-Host for the Impact of Obesity

Gut microbiota and its metabolites: Bridge of dietary nutrients and obesity-related diseases

The complex link between the gut microbiome and obesity-associated metabolic disorders: Mechanisms and therapeutic opportunities

Is the Gut Microbiota a New Factor Contributing to Obesity and Its Metabolic Disorders?

The gut microbiota, obesity and insulin resistance

Integrated omics analysis reveals the alteration of gut microbe-metabolites in obese adults

[The Intestinal Microbiota and Obesity of the Host].

Gut Microbiota and Adipose Tissue Microenvironment Interactions in Obesity

The critical role of gut microbiota in obesity

Gut microbiota in obesity and metabolic disorders

Gut Microbiota-Derived Short-Chain Fatty Acids Facilitate Microbiota:Host Cross talk and Modulate Obesity and Hypertension

Gut microbial metabolites in obesity, NAFLD and T2DM

Gut Microbial-Derived Short Chain Fatty Acids: Impact on Adipose Tissue Physiology